Controlled pore glass factor VIII concentrate: Influence of heat treatment

This publication has 12 references indexed in Scilit:

• A heat-treated factor VIII concentrate prepared by controlled-pore glass adsorption chromatography
  Transfusion, 1987
• Use of heat‐treated clotting‐factor concentrates in patients with haemophilia and a high exposure to HTLV‐III
  The Medical Journal of Australia, 1985
• Coincidental Appearance of LAV/HTLV-III Antibodies in Hemophiliacs and the Onset of the AIDS Epidemic
  New England Journal of Medicine, 1985
• ABSENCE OF ANTIBODIES TO AIDS VIRUS IN HAEMOPHILIACS TREATED WITH HEAT-TREATED FACTOR VIII CONCENTRATE
  The Lancet, 1985
• HTLV-III SEROPOSITIVITY IN EUROPEAN HAEMOPHILIACS EXPOSED TO FACTOR VIII CONCENTRATE IMPORTED FROM THE USA
  The Lancet, 1984
• RECOVERY AND INACTIVATION OF INFECTIOUS RETROVIRUSES ADDED TO FACTOR VIII CONCENTRATES
  The Lancet, 1984
• PREPARATION OF HIGH-PURITY FACTOR VIII BY CONTROLLED PORE GLASS CHROMATOGRAPHY
  The Lancet, 1981
• An Artificial ‘Haemophilic’ Plasma for One‐Stage Factor‐VIII Assay
  British Journal of Haematology, 1978
• Standard Techniques for the Measurement of Red‐Cell and Plasma Volume*
  British Journal of Haematology, 1973
• The in vivo Longevity of Antihaemophilic Factor (Factor VIII)
  British Journal of Haematology, 1964